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CAPSULE 
 
Background 
Several aspects of herpes simplexvirus ICP27-trafficking remains unclear. 
 
Results 
 
We investigated if ICP27 could interact with the nuclear pore complex, finding that ICP27 directly 
binds the core nucleoporin Nup62. 
 
Conclusions 
 
ICP27-association with Nup62 may provide additional binding sites at the pore for ICP27-shuttling. 
 
Significance 
 
We propose that ICP27 competes with some transport receptors, resulting in inhibition of host 
pathways and supporting ICP27-mediated transport of HSV-1 mRNAs.  
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ABSTRACT 
 
The herpes simplex virus ICP27 protein is 
important for the expression and nuclear 
export of viral mRNAs. Although several 
binding sites have been mapped along the 
ICP27 sequence for various RNA and protein 
partners including the transport receptor 
TAP of the host cell nuclear transport 
machinery, several aspects of ICP27 
trafficking through the nuclear pore complex 
remain unclear. We investigated if ICP27 
could interact directly with the nuclear pore 
complex itself, finding that ICP27 directly 
binds the core nucleoporin Nup62. This is 
confirmed through co-immunoprecipitation 
and in vitro binding assays with purified 
components. Mapping with ICP27 deletion 
and point mutants further shows that the 
interaction requires sequences in both the N- 
and C-termini of ICP27. Expression of wild-
type ICP27 protein inhibited both classical, 
importin α /β-dependent and transportin-
dependent nuclear import. In contrast, an 
ICP27 point mutant that does not interact 
with Nup62 had no such inhibitory effect. We 
suggest that ICP27 association with Nup62 
provides additional binding sites at the 
nuclear pore for ICP27 shuttling thus 
supporting ICP27-mediated transport. We 
propose that ICP27 competes with some host 
cell transport receptors for binding, resulting 
in inhibition of those host transport 
pathways.  
 
 
INTRODUCTION 
 
Herpesvirus replication involves a highly 
regulated temporal cascade of gene expression 
that depends greatly on the host cell nuclear pore 
complex (NPC)2 (1). Initially, the NPC is used 
for nuclear import of the viral genome (2). Then, 
when the virus lytic infection cycle proceeds, 
immediate early herpesvirus mRNAs are 
exported from the nucleus to make the 
immediate early-proteins in the cytoplasm that 
must be imported into the nucleus to activate the 
early genes that in turn are exported as mRNAs 
to make the early proteins, and this cycle repeats 
again for late genes and the late proteins 
(reviewed in 3).  
 The NPCs are the cellular mediators of 
transport in and out of the nucleus, assembled 
from multiple copies of over 30 different 
nucleoporin (Nup) proteins (4). Transport of 
macromolecules through the NPC is typically 
mediated by transport receptors that bind/coat 
the cargo and interact with Nups to negotiate the 
central channel of the NPC (reviewed in 5). 
Binding of transport receptors to cargos for 
nuclear import is signal sequence-mediated 
(reviewed in 6). Import receptors such as 
importin/karyopherin ß bind to classical basic 
nuclear localization signals (NLSs) (6). Some 
viral and cellular factors known to be involved 
in transport interact with a variety of transport 
receptors to facilitate recycling of proteins 
through the NPC. Human immunodeficiency 
virus (HIV-1) Rev protein interacts with 
multiple transport receptors including importin 
ß, transportin, importin 5 and importin 7 (7). 
Similarly, several ribonucleoproteins like 
hnRNP A1 are re-imported into the nucleus 
through binding of transportin-1 to M9 transport 
sequences that occur in many 
ribonucleoproteins. The transportin-1 uses 
interactions with core NPC Nups including 
Nup62 to mediate the translocation (8,9). CRM1 
is an export receptor for some RNA substrates, 
but mostly for proteins that bind to CRM1 
through their nuclear export signals (NESs) (10). 
CRM1 mediates the HIV-1 Rev shuttling via 
recognizing the Rev NES and binding to the 
NPC (10,11). TAP is the major cellular transport 
receptor for export of mRNAs (12,13). TAP-
mediated transport is usually facilitated by 
binding of REF/Aly to the cargo-receptor 
complex (14); however, TAP directly binds 
some viral RNA sequences like the constitutive 
transport element (15) of Mason-Pfizer monkey 
virus.  
 Viruses tend to evolve mechanisms to 
control or inactivate host cell nucleocytoplasmic 
transport through the NPCs. Several viruses 
interfere with nuclear import or export pathways 
via degradation and/or disruption of Nups and/or 
transport receptors (16-21). For example, 
vesicular stomatitis virus (VSV) Matrix (M) 
protein inhibits bulk host cell mRNA export by 
forming a complex with the mRNA export factor 
RAE1 and Nup98 (22) while influenza virus 
NS1 protein targets the mRNA export machinery 
by forming inhibitory complexes with the 
cellular export receptors TAP/NXF1, p15/NXT, 
Rae1/mrnp41, and E1B-AP5 (23). The result is 
the same, but in each case a viral-encoded 
protein associates with different NPC proteins to 
disrupt host cell transport. In other cases a core 
Nup is targeted for degradation e.g. poliovirus 
and rhinovirus inhibit nuclear import of proteins 
presumably by degrading Nup62 and Nup153 
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(17,18). Nup62 is located at the core of the NPC 
(24) and is directly targeted by several viruses 
(21,25,26). Yet other viruses provide their own 
transport receptors as in the case of the human 
T-lymphotropic virus (HTLV) Tax protein that 
directly interacts with Nup62 (27).  
 Herpes simplex virus (HSV) encodes 
ICP27, an immediate early protein required for 
expression of early and late HSV-1 gene 
products, particularly through enhancing the 
expression and export of intron-lacking herpes-
encoded mRNAs (reviewed in. 28,29). ICP27 is 
highly conserved among herpesviruses, with at 
least 30% amino acid identity among the 
herpesviridae (ORF57 in Kaposi’s Sarcoma-
associated herpes virus [KSHV], Mta/SM/EB2 
in EBV, UL69 in human cytomegalovirus 
[HCMV]). Both ICP27 and its KSHV and EBV 
homologues function as export factors (30,31) 
and are essential for virus replication (32,33). 
Viruses carrying mutations in ICP27 show 
reduced levels of viral mRNAs, are defective in 
viral DNA replication (34-37) and fail to 
efficiently suppress cellular gene expression 
(38).  
 ICP27 binds intronless HSV-1 mRNAs 
but not spliced viral transcripts through its RGG 
domain (28,29). The functions reported for 
ICP27 involve multiple steps of mRNA 
synthesis and processing, including 
transcription, splicing, nuclear export (28,29) 
and recently translation (39-41). Overall viral 
RNA export is strongly reduced, but not 
completely ablated during infection with ICP27 
mutant viruses. The remaining RNA export 
during herpes virus infection is probably in part 
due to the function of adaptors SRp20 and 9G8 
(42), which are serine-arginine rich (SR) 
proteins that control pre-mRNA splicing and can 
bind directly to the export receptor TAP/NXF1 
(reviewed in 43). Additionally there appear to 
be both ICP27-dependent and -independent 
pathways for different herpesvirus transcripts as 
during viral infection the long isoform of the 
UL24 transcript required ICP27 for its export 
whereas other viral transcripts such as gC and 
UL42 transcripts did not (44). ICP27 effects on 
translation are also mRNA specific; ICP27 
influences the expression of the essential HSV 
tegument protein and transactivator of 
immediate-early gene expression VP16 by 
inducing translation of VP16 mRNA likely at 
the level of initiation (41). On the other hand, 
polyribosomal analysis indicated that ICP27 is 
not required for efficient translation of two other 
early HSV transcripts (thymidine kinase and 
ICP8) (41).  
A variety of interaction sites have been 
identified along the ICP27 protein including an 
N-terminal LRR domain that binds RNA 
polymerase II CTD and Hsc70, a middle region 
that binds hnRNP K, and a C-terminal domain 
that also binds RNA polymerase II CTD, ICP8, 
protein kinase CK2β and SR proteins (reviewed 
in 28,29). The N- and C-terminal domains of 
ICP27 also fold intramolecularly to bind to one 
another (45) and ICP27 interacts with itself to 
form multimers via its C-terminal domain (46). 
Interestingly, the RNA polymerase II binding 
domain overlaps with the TAP/NXF1-binding 
site so that ICP27 and its associated RNAs can 
only be exported after release from the 
polymerase. 
ICP27 protein can shuttle in and out 
of the nucleus independent of viral mRNA 
(47,48) but ICP27 is observed primarily in the 
nucleus at steady state (28,29). For HSV-1 viral 
mRNA export, ICP27 principally operates 
through interactions with the host export 
receptor TAP/NXF1 (48) and the transport 
adaptor REF/Aly (47,49). Leucine-rich NES-
mediated export, dependent and independent of 
the CRM1 export receptor has also been 
reported (50); however, subsequent studies using 
the CRM1-inhibitor leptomycin B have shown 
that CRM1 is not absolutely required (47-49). 
Moreover, in Xenopus oocytes in the absence of 
viral RNAs export of ICP27 does not require 
either the known TAP/NXF1 or CRM1 receptors 
(47). These data argue for an alternative 
transport route for ICP27 nucleocytoplasmic 
shuttling, possibly, like the HTLV Tax protein, 
through direct interaction with Nups (27).  
To investigate an alternative mechanism 
of ICP27 trafficking we tested if ICP27, like 
Tax, could interact with Nup62. Both ICP27 and 
Nup62 co-immunoprecipitated with one another 
in HSV-1 infected cells and interacted in vitro 
using bacterially expressed tagged proteins. This 
interaction is RNA-independent and is 
conserved as it was also observed with another 
herpesvirus homologue. We propose that these 
additional binding sites at the NPC provide 
ICP27-bound viral mRNA-export complexes the 
advantage of facilitated export.  
 
 
EXPERIMENTAL PROCEDURES 
 
 Cells, Infection and Viruses — HeLa cells 
were grown in Dulbecco's modified Eagles 
medium (DMEM, Invitrogen) with 10% fetal 
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calf serum, 50 µg/ml penicillin and 50 µg/ml 
streptomycin at 37°C in 5% CO2. BHK cells 
were grown in Glasgow modified Eagles 
medium (GMEM, Gibco) supplemented with 
100 units/ml penicillin, 0.01% streptomycin, 
10% newborn calf serum and 10% tryptose 
phosphate broth. HSV-1 wild-type (WT) strain 
was propagated in BHK-21 cell line and ICP27 
complementing cell line, BHK derived M49 (51) 
was used for the growth and propagation of 
HSV-1 ICP27 viral mutants. Complementing 
cell lines were cultured in DMEM supplemented 
with 10% FCS and 5% tryptose phosphate broth. 
Selection was achieved by maintaining cells in 
800 µg of G418/ml and 750 µg of Zeocin/ml. 
Cells were infected with WT strain 17+ or 
KOS1.1, for infected cell lysates with ICP27 
viral mutants. Strain vBSGFP27 (52) expressing 
GFP fused to ICP27 under its own promoter was 
used for imaging. Alternatively cells were 
infected with ICP27 null virus d27-1 (∆27) 
where the ICP27 promoter and most of the gene 
coding sequence has been deleted (37), or ICP27 
mutant strains carrying the N-terminal deletion 
mutants dleu (53), d1-2 (54), d2-3 (55), d3-4 and 
d4-5 (56), d5-6 (56) and d6-7 (55), or C-terminal 
point mutants M15 and M16 (57). Virus was 
adsorbed onto cells for one hour and incubated 
at 37°C. Viruses were used at multiplicity of 
infections (MOIs) given in the figure legends.  
 
 Plasmids — GST–ICP27 (58), GST-
Nup62, GST-RaeI and GST-TAP (59) were kind 
gifts from Drs Steve A. Rice (University of 
Minnesota, Minneapolis, USA), Stuart A. 
Wilson (University of Sheffield, UK) and Elisa 
Izaurralde (Max Plank Institute, Tübingen, 
Germany) respectively and GST-ORF57 (30) 
and pCMV-10-ICP27 (60) have been described 
before. His-ICP27 encodes ICP27 fused to the 
N-terminal His tag from the pET28 vector. 
mRFP-ICP27 WT and M15 recombinant (ICP27 
P465L:G466E) plasmids were constructed by 
moving the EcoRI/BamHI insert of pEGFP-C1-
ICP27 WT and M15 into the mRFP-C1 vector 
(R. Tsien, USA). ICP27 WT and deletion 
plasmids amino acids 10-512, 166-512 and 1-
403 expressed from pTriEx1.1-ICP27 have been 
described earlier (47). The reporter plasmid 
Rev48-116-GFP2-cNLS (NES-GFP2-cNLS) was 
described in (61). For construction of NES-
GFP2-M9, the HIV-1 Rev sequence containing 
the NES (amino acids 48-116) was PCR-
amplified and inserted into XhoI and SpeI sites 
of a modified pEGFP-C1 vector coding for a 
GFP-GFP fusion protein with a C-terminal M9-
sequence (the NLS of hnRNPA1) (62).  
  
 Cell Lysis and Fractionation — For co-
immunoprecipitation experiments, total cellular 
protein lysates were obtained by scraping cells 
into NP40 lysis buffer (0.5 % NP-40, 150 mM 
NaCl, 50 mM Tris pH 8.0, 2 mM EDTA, 10% 
glycerol) with either addition of ionic detergents 
[0.5% sodium deoxycholate and 0.1% SDS], or 
mechanical shearing by passing cells through a 
syringe, followed by treatment in a sonibath, 
with fresh addition of complete mini protease 
inhibitor cocktail mix (Roche) and complete 
phosphoSTOP (Roche). Shearing was done by 
10 passes through a 26 gauge needle and 
sonication was for 30-60 s cycles for 10 min in a 
sonibath and then lysates were left rotating at 
4°C for 30 min for solubilization. Debris was 
pelleted by centrifugation at 13,000 x g for 10-
30 min in a 4°C microfuge. For Western blot 
analysis eluted proteins were mixed with 2x 
SDS sample buffer while whole cell lysates were 
generated by scraping cells directly into 2x SDS 
sample buffer. In order to standardize the 
amount of protein added to 
immunoprecipitations or pull downs, cell 
numbers were counted and cell equivalents of 
total cell protein content of soluble protein 
extracts was determined by Bradford assay or 
the various fractions were compared on SDS-
polyacrylamide gels and Western blotted to 
examine protein expression. 
 
 Western Blot Analysis And Antibodies — 
Proteins were fractionated by SDS-PAGE and 
transferred to nitrocellulose membranes. 
Membranes were blocked with 5% milk powder 
in PBS containing 0.1% Triton-X-100 (PBST) 
either overnight at 4°C or for 1 h. Membranes 
were incubated with primary Abs in the same 
buffer for 1-2 h at RT or overnight at 4°C, 
washed, and incubated with anti-mouse IgG, 
anti-rabbit IgG or anti-goat IgG conjugated to 
horseradish peroxidase for 1 h with shaking. 
Following washing in PBST, proteins on 
membranes were visualized either using ECL 
(GE Healthcare) and exposed to Kodak X-
OMAT S film or analysed directly on a Li-COR 
Odyssey (Li-COR Biosciences) using antibodies 
conjugated to fluorescent markers. Monoclonal 
primary antibodies (Abs) used were against 
ICP27 (1119/1113, Virusys Corporation; 
1:2,000), GAPDH (Cat No. 4300, Ambion; 
1:10,000), His-tag (Novagen), P53 Ab (DO-1, 
BD Pharmingen; 1:500), PML Ab (5E10), 
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Nup98 (2H10, AbCam, 1:1000) and TAP/NXF1 
(G-12) (sc-28377, Santa Cruz Biotechnology; 
1:100). Polyclonal Abs used were against 
GAPDH (E1C604-1, 1:500) from Enogene and 
TAP/NXF1 (H-120 — sc-25768; 1:1000) and 
Nup62 (H-122, D-20 and N-19) from Santa Cruz 
Biotechnology.  
 
 Microscopy — 8 × 104 cells were grown 
on each 18 × 18 mm coverslip overnight, then 
infected with virus or mock infected for the 
times stated. Coverslips were washed three times 
with PBS and fixed with 3.7% formaldehyde for 
10 min, then permeabilized with 0.2% Triton X-
100 for 5 min at RT for fixation and finally 
washed three times with PBS. Alternatively, 
cells were first pre-extracted with 1% Triton X-
100 in 25 mM Hepes pH 7.4, 150 mM KOAc, 
15 mM NaCl, 5 mM MgSO4 for images in Fig. 1 
for 1 min, washed with PBS, and then fixed with 
formaldehyde. Coverslips were blocked with 
PBS containing 10-20% serum, 200 mM glycine 
or 5% BSA for 1 h at room temperature, then 
incubated with primary Abs diluted in 5% BSA 
or 1% calf serum in PBS for 1 h at room 
temperature: ICP27 (1119/1113, 1:400, Virusys 
Corporation), mab414 (1:500; Covance), Nup62 
(N-19; 1:50, Santa Cruz Biotechnology), TAP 
(1:200, gift from Elisa Izaurralde). Coverslips 
were washed in PBS six times before incubation 
for 1 h with secondary Abs (Jackson 
Laboratories, donkey minimal cross-reactivity) 
diluted in 5% BSA or 1% (v/v) calf serum in 
PBS. After washing in PBS six times, cells were 
incubated with 4’,6-diamidino-2-phenylindole 
(DAPI; 1:2000) as a nuclear stain and washed 
with PBS and coverslips were mounted with 
fluoromount G (EM Sciences) mounting 
medium. Images were taken using a Nikon 
TE2000-U microscope with a 1.45 NA 100X 
objective, Sedat quad filter set, PIFOC z-axis 
focus drive (Physik Instruments), and 
CoolSnapHQ High Speed Monochrome CCD 
camera (Photometrics) using IPLab4.0 and 
Metamorph acquisition software. For figure 1 
image stacks (0.2 µm steps) were deconvolved 
using AutoquantX and all images were 
processed using Adobe photoshop CS2. 
 
 Co-immunoprecipitation Of Infected Cell 
Extracts — For immunoprecipitations, protein 
A/G–Sepharose beads were washed three times 
in NP40 lysis buffer. Beads were used to pre-
clear cell lysates by incubation for 1 h at 4°C 
with rotation. When required mock or virus-
infected cells were treated with 20 ng/ml LMB 
(Sigma) for 3 h prior to harvesting. Where stated 
cell lysates (500 µg) were RNase I-treated (100 
U) prior to use by incubation for 1 h at 37°C. 
Cell extracts were mixed with the anti-ICP27 
Abs H1119 and H1113 or anti-Nup62 Abs or 
negative control Abs for 2 h in binding buffer 
and protein A/G–Sepharose beads were added 
for another 2 h or overnight. The precipitates 
were washed five times with cold IPP150 (10 
mM Tris–HCl pH 8, 150 mM NaCl, 1% Triton 
X-100) and eluted. Bound eluate was suspended 
in SDS-PAGE loading buffer, heated for 5 min 
and analyzed by SDS-PAGE. Western blot 
analysis was performed using Abs as described 
in the figure legends. 
 
 Protein Expression In E.coli — 
Expression of GST–TAP (59) and GST-ORF57 
(30) recombinant proteins has been described. 
GST–ICP27 (58), GST–Nup62, GST-RaeI and 
GST alone recombinant proteins were expressed 
in E.coli BL21 cells and purified on glutathione-
Sepharose beads (GE healthcare) as described 
(60). Histidine-tagged-ICP27 from pET-ICP27 
was expressed in BL21 DE3 and purified using 
Talon resin (Clontech) as described (47). Fusion 
proteins immobilized on beads were pre-treated 
with 0.2 U DNase I and 0.2 µg RNase I per µl 
for 30 min at 20°C in 50 mM Tris-HCl pH 8.0, 5 
mM MgCl2, 2.5 mM CaCl2, 100 mM NaCl, 5% 
glycerol, 1 mM DTT. Beads were washed twice 
with 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 
mM EDTA, 0.5% NP-40, 1 mM DTT, and 
blocked in the same buffer containing 10 mg/ml 
BSA for 30 min at 4°C. After blocking, the 
beads were resuspended in binding buffer 
containing 1 mg/ml BSA prior to use. 
 
 In Vitro Pull Down Assays — GST–
Nup62 binding reactions were carried out in 500 
µl of 10 mM Tris–HCl pH 8.0, 150 mM NaCl, 
1% Triton X-100, 10% glycerol buffer, using 5 
µg of GST-fusion protein bound to 20 µl of 
glutathione-Sepharose 4B, together with 100 µg 
of mock- or virus-infected cell lysates or 5 µg of 
purified His-ICP27 protein. In some experiments 
cell lysates were treated with 5 µg of RNase I 
prior to binding reactions. Proteins were eluted 
from the resin using elution buffer (50 mM Tris–
HCl pH 8.0, 20 mM glutathione) and analyzed 
by SDS–PAGE. 
 
 Transient Transfection — For ectopic 
expression of ICP27, HeLa cells on coverslips in 
24-well dishes were transiently transfected with 
0.1 µg per well pCMV-10-ICP27 (tr27) using 
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fugene HD (Roche). Medium was replaced after 
24 h. Cells were fixed 48 h after transfection and 
processed for immunofluorescence microscopy.  
 
 Transport Assays — To analyze 
inhibition of nuclear import, HeLa cells on 
coverslips in 24-well dishes were transiently 
transfected with 0.125 µg NES-GFP2-cNLS or 
NES-GFP2-M9, respectively, with or without 
0.25 µg pCMV-10-ICP27 or pmRFP-C1 plasmid 
encoding WT ICP27 or mRFP-ICP27 M15 
mutant, using Polyfect according to the 
instructions of the manufacturer (Qiagen). For 
pTriEx-ICP27 WT and deletion mutant 
expression cells were transfected with 0.5 µg 
plasmid DNA using Fugene HD (Roche). After 
24 h, cells were fixed and processed for 
immunofluorescence microscopy, using the anti-
ICP27 Ab or analyzed directly in case of mRFP 
tagged ICP27. Cells were analyzed by 
fluorescence microscopy with a Zeiss 
Axioskop2 microscope and AxioVision software 
for those in figure 8 and a Nikon TE2000-U 
microscope with a 1.45 NA 100X objective, 
Sedat quad filter set and CoolSnapHQ High 
Speed Monochrome CCD camera 
(Photometrics) using IPLab4.0 and Metamorph 
acquisition software for those in figure 9. 
Pictures were processed using Adobe Photoshop 
(San Jose, CA). 
 
 
RESULTS 
 
 A subpopulation of ICP27 associates at 
the nuclear rim — ICP27 contributes to nuclear 
export of viral mRNAs and is known to partly 
colocalize with the cellular mRNA export factor 
TAP at early times after infection in the nucleus 
(48,49). Thus ICP27 co-localization with TAP 
and with the NPC itself was investigated. In 
HSV-1 infected cells, ICP27 shows largely 
diffuse distribution throughout the nucleoplasm 
with some punctate spots (63). Strong signals 
from the large nucleoplasmic pool of ICP27 (see 
below) makes it difficult to distinguish if a 
separate pool of ICP27 is stably associated with 
the NPC. Many nuclear envelope proteins 
including Nups and some transport receptors 
resist a pre-fixation extraction with detergent 
because of their interactions with the highly 
stable structures of the nuclear lamin polymer 
and the NPC (64,65). So detergent extraction 
was used to determine if a sub-population of 
ICP27 is stably associated with the NPC. 
Accordingly, in Triton-X-100 pre-extracted cells 
some of the nucleoplasmic free ICP27 is washed 
away leaving both punctate accumulations in the 
nucleoplasm and a clear rim at the nuclear 
periphery (Fig. 1A). This peripheral pool of 
ICP27 co-localizes (yellow) at the rim with 
FxFG nucleoporins stained with mab414 that 
recognizes several nucleoporins including 
Nup62, 98, 153 and 214, based on their unique 
O-linked glycosylation. Co-localization is 
observed at 8 and 16 h post-infection, but not 
visible at 4 h post-infection (Fig. 1A).  
 TAP that also stably associates with the 
NPC has a significant nucleoplasmic pool, like 
ICP27, that is mostly washed away by the triton 
pre-fixation extraction (data not shown). The 
remaining TAP protein co-localizes with ICP27 
at the nuclear periphery (Fig. 1B). Notably, the 
distinct nucleoplasmic pool of ICP27 did not 
colocalize with TAP. This internal ICP27 could 
be associated with viral replication centers, 
indicating that there are at least three distinct 
subpopulations of ICP27 during virus infection: 
nucleoplasmic extractable, nucleoplasmic 
resistant, and peripheral resistant. The 
significant amount of ICP27 remaining 
associated in close proximity of the NPC is 
consistent with expectations that ICP27 actively 
shuttles and/or remains associated with viral 
transcripts during transport.    
ICP27 protein export in the absence of 
viral RNA requires neither TAP nor CRM1 as 
use of constitutive transport element RNA or 
NES conjugates to block the TAP and CRM1 
pathways respectively did not inhibit 
cytoplasmic accumulation of ICP27 when re-
import of ICP27 was inhibited (47). Thus an 
alternative route for export must exist. We 
postulated that the ICP27 that resisted Triton 
extraction might indicate an alternative route 
involving direct interactions with core structural 
components of the NPC. In keeping with both 
poliovirus and HTLV proteins that interact 
directly with Nup62, a core structural 
component of the NPC central channel, we 
chose to test for possible interactions of ICP27 
with Nup62. Some virus interactions with Nups 
result in degradation or redistribution of NPC 
components as happens during poliovirus 
infection (16-21,25,26). Therefore, we first 
tested Nup62 protein levels and localization in 
HSV-infected cells. Protein levels were assayed 
by Western blotting of extracts from cells that 
were mock infected or infected with either WT 
HSV-1 or HSV-1 carrying a deletion of the 
ICP27 gene (∆27). During lytic infection with 
HSV-1 at MOI 10, ICP27 protein starts to 
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express as early as 2-3 h post infection (hpi) 
(Fig. 2A, first panel). The levels are readily 
detectable by 4 h (Fig. 2A, middle panel) and 
peak between 8-16 h (not shown). GAPDH 
staining confirmed similar protein loading. As 
cell lysis begins to occur several hours after 
ICP27 levels have peaked, ICP27 accumulation 
was also tested at 24 h at a lower MOI. ICP27 
was abundant still at 24 h post-infection, when 
infected with HSV at an MOI of 1 (Fig. 2A, last 
panel).  No difference in Nup62 protein levels 
could be observed between mock, WT and 
ICP27 null virus infected cells at the times tested 
(Fig. 2A) showing that HSV-1 does not 
downregulate Nup62 levels.  
Next we looked at the effect of HSV-1 
infection on Nup62 localization by 
immunofluorescence. As the aim was to look at 
the total levels of intact Nup62 in infected cells 
we chose to analyze Nup62 in directly-fixed 
cells without triton pre-extraction. Nup62 
(green) remains at the nuclear envelope in non-
extracted directly-fixed cells, regardless of the 
presence of ICP27 (red; in 3 and 18 hpi cells) 
(Fig. 2B). Similar to an earlier report of changes 
in nuclear pore composition in some uninfected 
and infected cells (66) we also noted the 
presence of some microclusters of Nup62 around 
the nuclear rim at 18 hpi and a distinct speckled 
cytoplasmic staining in many cells where 
nuclear integrity was still intact (late HSV-1 
infection compromises nuclear integrity) as 
observed by DAPI staining. Thus, unlike during 
infection by several other viruses where Nup62 
is either degraded or heavily mislocalized, in 
HSV-infected cells Nup62 protein levels are not 
much different compared to mock-infected cells 
but may cluster at the nuclear periphery late in 
infection.  
 
ICP27 interaction with Nup62 revealed 
by co-immunoprecipitation — To test for a 
physical association between ICP27 and Nup62, 
immunoprecipitation (IP) assays were 
conducted. Nup62 protein was co-
immunoprecipitated with ICP27 Abs only in 
cells infected with WT virus, but not in cells 
infected with the ICP27-null virus or mock 
infected cells (Fig. 3A). The absence of ICP27 
protein in the mock and ICP27-null virus 
immunoprecipitated lysates was confirmed with 
staining the immunoprecipitated fractions with 
ICP27 Abs. The presence of Nup62 protein in all 
the lysates used was confirmed in the unbound 
panel and the absence of an interaction with 
control serum Abs (ctr) showed the specificity of 
the interaction with ICP27 Abs. 
In a reverse experiment ICP27 protein 
was co-immunoprecipitated with Nup62 Abs. In 
agreement with the above data, no interaction 
was observed in mock infected and ICP27-null 
virus infected cell lysates (Fig. 3B). In addition 
to the interaction observed in WT virus infected 
cell lysates, an interaction was observed in cell 
lysates from M16 HSV-1 infected cells. M16 is 
a mutant virus strain that has a point mutation in 
the Zn finger motif at the C-terminus of ICP27 
(C488L). This mutation has been shown to block 
interaction with TAP (48). The interaction 
between ICP27 and Nup62 is not mediated by 
viral RNA as has been shown for the TAP/NXF1 
interaction (48) because interactions were 
maintained upon treatment of cell extracts with 
RNase I both during the lysis stage and during 
immunoprecipitation reactions (Fig. 3B and 
Supplementary Fig. S1). Treatment with RNAse 
I may provide more sites for specific protein-
protein complex formation by reducing the 
amount of transport receptors bound to RNAs. 
This could be the reason that more ICP27 co-
immunoprecipitated with the anti-Nup62 Ab in 
the presence of RNAse I. Again, non-specific 
serum Abs served as a negative control and 
Nup62 Abs immunoprecipitated Nup62 protein 
in all lysates (Fig. 3B, lower panels). To address 
the possibility that another Nup might mediate 
the interaction between ICP27 and Nup62, 
several different Abs against different epitopes 
of Nup62 were employed with the same result 
(data not shown). Additionally, the possibility 
that this in vivo interaction between ICP27 and 
Nup62 was specific and does not co-
immunoprecipitate irrelevant non-specific 
proteins was investigated by probing anti-Nup62 
co-immunoprecipitations with antibodies to a 
non-specific protein (Supplementary Fig. S2)). 
The above reactions were performed 
using human HeLa cells. To ensure that potential 
differences in the character of virus infection 
and cellular proteins do not contribute to the 
observed ICP27-Nup62 interaction, we also 
tested for this interaction using hamster BHK 
cells that are more permissive for HSV-1 
infection. A similar interaction between ICP27 
and Nup62 was observed in BHK cells (Fig. 
3C). Additionally, in this experiment different 
concentrations of WT infected lysate were used. 
The relative increase in the ICP27-Nup62 
interaction by varying input amounts of lysates 
with the same antibody concentrations shows 
that the antibodies were not saturated in these 
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experiments and supports the specificity of the 
interaction. As a positive control for ICP27 
immunoprecipitation, ICP27 was also 
immunoprecipitated from WT HSV-1 infected 
BHK cell lysates with Abs against ICP27 and 
run on the same gel (Fig. 3C, far right lane).  
 
 The ICP27-Nup62 interaction is verified 
by pull down assay with bacterially purified 
components — To further confirm the 
interaction of ICP27 with Nup62 we expressed 
and purified GST and GST-Nup62 from bacteria 
and used these proteins to pull down ICP27 from 
HSV-infected and mock-infected cell extracts. 
Western blotting with anti-ICP27 Ab showed 
that GST-Nup62 pulled down ICP27 from WT 
infected cell extracts (Fig. 4A) but not from 
ICP27-null infected and mock-infected cell 
extracts. The ICP27 interaction with Nup62 does 
not require the presence of other viral proteins as 
GST-Nup62 could also pull down ICP27 from 
uninfected HeLa cells expressing ICP27 protein 
from a transfected plasmid (Fig. 4A, tr27). GST 
failed to pull down ICP27 from WT HSV-1 
infected cell extracts. Bacterially expressed 
proteins including GST-Nup62 and GST used in 
these assays are shown in figure 5C. GAPDH 
Ab confirmed that similar amounts of cell 
extracts were added to all pull downs (Fig. 4A, 
lower panel). The interaction with endogenous 
proteins was RNA-independent as it occurred in 
RNase I treated extracts (Fig. 4B and 
Supplementary Fig. S1). As a control, another 
GST fusion protein Rae1 (see below) which is 
an mRNA export factor involved in 
nucleocytoplasmic transport was incubated with 
extracts of cells infected with either WT HSV-1, 
∆27 null, a C-terminal ICP27 point mutant 
(P465L:G466E) HSV-1 strain (M15) or mock 
infected cell extracts (Fig. 4C). Proteins co-
purifying on Glutathione Sepharose beads were 
analyzed by Western blotting with an Ab against 
ICP27. Neither GST alone nor GST-Rae1 pulled 
down ICP27 from any of the cell extracts, which 
can be seen in the input cell extract lane (upper 
panel). A doublet band of greater mobility in 
lanes 2-5 and marked with an asterisk is a band 
from the GST-Rae1 bacterial protein preparation 
cross-reacting non-specifically with anti-ICP27 
Ab. Input cell extracts and GST alone served as 
a control for ICP27 in pull downs. GAPDH 
levels in the lysates served as a loading control 
for these experiments (lower panel). Bacterially 
expressed GST-Rae1 protein used in binding 
assays (Fig. 4C) is shown on a Coomassie 
stained gel (Fig. 4D).  
As a positive control for a Rae1 
functional interaction, its ability to bind a known 
partner protein, Nup98 (67), independent of 
presence of ICP27, was tested. Bacterially 
purified GST-Rae1 or GST was incubated in 
presence of RNase I with extracts of cells 
infected with ∆27 null mutant HSV-1 strain or 
mock infected. Proteins co-purifying on 
Glutathione Sepharose beads were analyzed by 
Western blotting with an Ab against Nup98. 
GST-Rae1 pulled down Nup98 from ∆27 
infected as well as mock infected cell lysates 
(Fig. 4E, bound fraction). A similar result was 
obtained for TAP that interacts with Nup98 (68) 
using bacterially purified GST-TAP (Fig. 4E, 
bound fraction). These data demonstrate that in 
our assay bacterially purified GST-RaeI and 
GST-TAP were able to bind partner protein 
Nup98 and RaeI-Nup98 and TAP-Nup98 
complexes are formed in the mock as well as 
virus-infected cells in an RNA-independent 
manner. Thus, though ICP27 is known to bind 
TAP receptor, it does not appear to compete 
with TAP binding to Nup98. GST alone showed 
a weak band as background in bound samples; 
however, the majority of Nup98 is not pulled 
down and is present in unbound samples with 
GST alone whereas no Nup98 is left as unbound 
with mock lysates (Fig. 4E).  
 
 The Nup62-ICP27 interaction is 
direct— TAP has previously been shown to bind 
to ICP27 at both ends (48). Therefore GST-TAP 
was used as a positive control for proper folding 
of the bacterially purified tagged ICP27 protein 
(see below). First, GST-TAP was able to pull 
down ICP27 from WT HSV-1 infected cell 
extracts (Fig. 5A upper panel) but not from the 
ICP27-null virus infected extracts (Δ27) nor 
from extracts of cells infected with an HSV-1 
mutant strain carrying a C-terminal point 
mutation in ICP27 at the known site of 
interaction with TAP (M15). As a negative 
control, GST failed to pull down ICP27 from 
WT HSV-1 infected cell extracts. TAP interacts 
with Nup62 (68) so, as a specificity control for 
the binding reactions shown above, GST-TAP 
was tested to determine if it was able to interact 
with Nup62 under the same conditions. Western 
blot with anti-Nup62 Ab showed that GST-TAP 
pulled down Nup62 from WT HSV-1 infected 
cell lysates (Fig. 5A lower panel) as well as from 
the ICP27-null virus infected lysates and from 
lysates of cells infected with an HSV-1 virus 
carrying a C-terminal point mutation in ICP27 
(M15) and mock cells. This demonstrates that 
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TAP-ICP27 (Fig. 5A upper panel) and Nup62-
ICP27 complex (Fig. 4 A and B) formed in the 
WT virus-infected cells whereas the TAP-Nup62 
complex formed in both infected (WT, null and 
M15 mutant) and mock infected cells (Fig. 5A 
lower panel). To test the RNA requirement for 
the above binding we performed anti-ICP27 co-
immunoprecipitations in the presence of RNase I 
from various HeLa cell lysates. Western blotting 
with anti-TAP antibodies showed co-
immunoprecipitation of TAP in WT infected 
HeLa cell lysates in the presence of RNase I by 
ICP27 but no co-immunoprecipitation with M15, 
Δ27 and mock infected lysates (Fig. 5B upper 
panel). Mock infected RNase treated HeLa cell 
extracts were used as an input positive control 
for TAP. ICP27 immunoprecipitated itself in 
WT and M15 infected HeLa cell lysates in the 
presence of RNase I but no co-
immunoprecipitation was observed in Δ27 and 
mock infected cell lysates (Fig. 5B lower panel).  
To test if ICP27 interacts with Nup62 
directly, independent of any other bridging 
factor, His-tagged ICP27 and GST-Nup62 were 
expressed and purified from E. coli for use in an 
in vitro pull down assay. Various proteins used 
in the in vitro binding assays are shown in figure 
5C. Western blotting was performed on bound 
samples using anti-His Ab to identify the bound 
full-length His-tagged ICP27 protein. Both the 
purified GST-TAP and GST-Nup62 were able to 
pull down the purified His-ICP27 in the absence 
of other viral or mammalian cell proteins (Fig. 
5D), confirming that GST-p62 interacts directly 
in vitro with ICP27. The ratio of bound 
bacterially purified protein compared to the 
input consistently appeared to be less than the 
ratio when ICP27 was bound from mammalian 
cell lysates (Fig. 4A and B) suggesting that some 
posttranslational modifications may contribute 
additively to this complex formation. Again, as a 
negative control GST alone failed to pull down 
His-ICP27. The bacterially purified proteins in 
our preparation contain cleavage products of the 
full-length fusion proteins because it is quite 
difficult to express and purify non-cleaved full-
length proteins from ICP27-family of herpes 
viral proteins. Although lack of full purification 
means that there is a possibility that other 
bacterial proteins in the ICP27 fusion protein 
preparation mediate any interaction. However, 
we have included a number of internal negative 
and positive controls in binding assays that 
argue against this possibility. Moreover a 
positive ICP27-Nup62 co-immunoprecipitation 
occurring with high salt titration (wash with 
500mM NaCl) provides additional evidence of 
specificity of binding (data not shown).   
Additionally for the direct in vitro pull 
down assay the specificity was further confirmed 
using an irrelevant, non-specific His-tagged 
fusion protein (His-mRFP) expressed in bacteria 
and purified to the same extent as the IPC27 
fusion proteins. The His-mRFP fusion protein, 
present in all binding reactions, (Fig. 5E, upper 
panel: band corresponding to the input lane; 
lower panel: all lanes) did not interact with GST-
TAP, GST-Nup62 or GST alone in pull down 
assays. Hence ICP27 binding to GST-TAP and 
GST-Nup62 was likely not due to poor protein 
preparation or other bacterial proteins mediating 
the binding  
 
 The Nup62-ICP27 interaction is 
conserved across herpesviridae — GST-fusion 
proteins were also purified for ICP27 and its 
KSHV homologue ORF57. Both were able to 
pull down Nup62 from HeLa cell extracts (Fig. 
6A). Moreover, the amount of Nup62 
associating with GST-ICP27 and GST-ORF57 
from the HeLa extracts was very similar (Fig. 
6A). No interaction occurred between Nup62 
and GST, confirming the specificity of the 
interaction (Fig. 6A, last lane). The lower band 
marked with an asterisk in lane 2 is possibly a 
band from the GST-ICP27 protein preparation 
cross-reacting non-specifically with Nup62 Abs. 
To further confirm that non-specific irrelevant 
proteins did not also bind to ICP27 or ORF57 
fusion proteins, pulled down reactions were 
blotted with anti-GAPDH Ab. This showed 
GAPDH present only in the input and not in the 
pulled down samples (Fig. 6B). GST-ICP27, 
GST-ORF57 and GST alone present on the 
beads used in the binding reactions are shown in 
Figure 6C. 
 
 Mapping of binding of Nup62 on ICP27 
— To map the interacting regions of ICP27 with 
Nup62 we used purified GST-Nup62 and GST 
alone to pull down ICP27 from cell lysates 
infected with WT virus or a panel of ICP27 
mutant viruses. The mutants (Fig. 7A) have been 
previously used for other mapping studies to 
define the functional domains of ICP27 (37,53-
56). In particular, a series of deletion viruses 
covering the whole N-terminal region was tested 
including deletions in the NES, NLS, and RGG 
sequences. Additionally, ICP27 C-terminal point 
mutant viruses M15 (P465L:G466E) and M16 
(C488L) were tested (57); the position of these 
mutations is shown with double and single 
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asterisks in the ICP27 cartoon in Figure 7A. 
GST-Nup62 pulled down all N-terminal ICP27 
deletion mutants except for dLeu (aa6-19) that 
removed the NES (Fig. 7B). Despite significant 
levels of expression of the ICP27 protein from 
dLeu mutant virus as seen in unbound lysate 
fractions (Fig. 7B, lower panels), no ICP27 was 
pulled down with GST-Nup62. In contrast, other 
ICP27 N-terminal mutant proteins like those 
from d1-2 and d3-4 viruses bound to GST-
Nup62, as did ICP27 deletions up to d6-7 
confirming that apart from the extreme N-
terminus most of the N-terminal region is not 
required. However the N-terminal leucine-rich 
region may contribute to the interaction of 
ICP27 with Nup62. Interestingly, neither C-
terminal mutant of ICP27 (M15, M16) was 
pulled down by the GST-Nup62. It is known that 
expression of ICP27 protein from these C-
terminal mutant viruses (M15, M16) is reduced 
as compared to that of the ICP27 protein from 
the WT virus (48): we see this also in the 
unbound lysates (Fig. 7B, lower panels). 
Nonetheless, the absence of an interaction with 
viral M15 and M16 C-terminal mutants was not 
due to our inability to analyze this interaction 
due to the reduced expression levels of ICP27 
mutant protein. When the amount of M15 and 
M16 input lysates added to the GST-Nup62 pull 
down reactions was increased the C-terminal 
mutants still failed to pull down detectable levels 
of ICP27 (data not shown). Lack of interaction 
of GST-Nup62 with mock and ICP27-null virus 
infected lysates (Fig. 7B) and the GST control 
with WT (far right lane) indicated the specificity 
of the binding reactions. Thus the C-terminus 
and a small region of the N-terminal segment 
appear to be important for ICP27 interactions 
with Nup62.   
 
ICP27 blocks both M9 and NLS -
mediated nucleocytoplasmic transport pathways 
— The ability of ICP27 to interact directly with 
a core NPC protein in an RNA-independent 
manner suggested that ICP27 might have either 
a more direct role in its own shuttling/recycling 
or additional as yet undefined effects on other 
nucleocytoplasmic transport pathways during the 
course of HSV-1 infection. To test for an effect 
on other transport pathways ICP27 was 
expressed together with cargo reporters for 
different transport pathways. Both reporters had 
two GFP moieties in tandem to bring them 
above the free diffusion limit for NPC transport 
and were able to shuttle. On the N-terminus of 
both was the HIV Rev NES, which is exported 
in a CRM1-dependent manner, but this was 
countered by an M9 signal or strong NLS at the 
C-terminus. The first reporter, NES-GFP2-M9 
carried the M9 sequence from hnRNP A1 (69) 
that utilizes transportin as an import receptor and 
is independent of importin/karyopherin α and β 
(70). At steady state, this reporter accumulates in 
the nucleoplasm in HeLa cells (Fig. 8A, middle 
row central panel), apparently because import is 
dominant over export. When plasmid (pCMV-
ICP27)-encoded ICP27 was co-expressed with 
the M9 reporter (Fig. 8A, lower right panel), the 
predominant nuclear localization of the M9 
reporter construct was largely abolished (Fig. 
8A, middle right panel). Now the reporter was 
equally distributed between the two 
compartments, demonstrating an inhibition of 
the transportin pathway by ICP27. ICP27 is a 
shuttling protein: at steady state, however, it 
mostly localizes to the nucleus with some 
cytoplasmic localization. The amount of ICP27 
cytoplasmic localization depends on the cell 
type, levels of expression, and the time post 
infection. At late times post infection where 
there are both elevated levels of ICP27 and of 
transcribed viral mRNAs, ICP27 localizes also 
to the cytoplasm, possibly shuttling faster with 
its substrate mRNAs (47). When ICP27 alone 
was expressed ectopically from a plasmid 
(pCMV-ICP27) without the reporter and in the 
absence of infection, the ICP27 accumulated in 
both the nucleus and cytoplasm of the cells (Fig. 
8A, lower left panel). The partial cytoplasmic 
localization of ICP27 expressed from plasmid 
DNA could result from the lack of viral RNA 
substrates. But also higher expression levels of 
ICP27 may push some into the cytoplasm. Upon 
co-expression with reporter cargo receptors, 
ICP27 localization also appeared to be slightly 
more cytoplasmic (Fig. 8A, lower right panel) 
possibly as a result of competition for or, 
saturation of common factors at nuclear pores. 
The NES-GFP2-M9 reporter construct also 
accumulated in the cytoplasm when co-
transfected with another plasmid (pTriEx-
ICP27) encoding full-length ICP27 WT protein 
(Fig. 8B middle panel) further supporting an 
inhibition of the transportin pathway by ICP27.  
To determine if ICP27 inhibition of 
transport is unique to the transportin-dependent 
pathway or if ICP27 can inhibit multiple 
pathways, a second reporter (NES-GFP2-cNLS) 
representing the classical importin/karyopherin 
α/β-dependent import was assayed. This reporter 
carried the SV40 classical basic NLS. It is able 
to shuttle because its export out of the nucleus is 
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mediated by the HIV Rev NES in a CRM1-
dependent manner. At steady state, it localized 
almost exclusively in the nucleus, apparently 
because its import is dominant over export (Fig. 
8C, left middle panel). When ICP27 was co-
expressed with the NES-GFP2-cNLS reporter 
(Fig. 8C, right panels), the reporter was observed 
predominantly in the cytoplasm (Fig. 8C, right 
middle panel) along with ICP27 (Fig. 8C, right 
lower panel). Thus ICP27 also inhibits the 
importin/karyopherin transport pathway. Images 
shown (Fig. 8) are the representative of at least 
three experiments performed. A similar 
phenotype of reporter localization distribution 
also to the cytoplasm was observed in more than 
90% of dual co-transfected cells. Very few 
(<10%) dual transfected cells showed only 
nuclear localization of the reporters.   
To test if this ability of ICP27 to inhibit 
multiple host cell nucleo-cytoplasmic transport 
pathways was likely to require its interaction 
with Nup62, the ICP27 C-terminal mutant M15 
that did not interact with Nup62 (Fig. 7B) was 
expressed from a plasmid independently of viral 
infection (Fig. 9A and Fig. 9B and C, second 
panels). The plasmid construct was used because 
M15 protein levels were lower than WT ICP27 
in cells infected with mutant viruses. To 
determine if this approach increased M15 levels, 
lysates from cells expressing WT ICP27 or the 
mutant were analyzed by Western blotting 
(Supplementary Fig. S3). Indeed this yielded 
similar protein levels for comparison and at 
similar exposure times, fluorescence intensity of 
proteins expressed from both was similar too 
(data not shown). For these experiments both the 
M9 reporter construct that utilizes transportin as 
an import receptor (NES-GFP2-M9) and the 
cNLS reporter construct that is dependent on the 
importin/karyopherin α/β pathway (NES-GFP2-
cNLS) were used. Unlike the WT ICP27 that 
redistributed the reporter to the cytoplasm, the 
M15 mutant yielded predominantly nuclear 
staining for the reporters (Figs. 9B and 9C, 
second panels). This suggests that the interaction 
of Nup62 with the C-terminal region of ICP27 is 
required for ICP27 inhibition of host cell 
transport. 
Other ICP27 mutants (Fig. 9A) were 
also examined for their effects on the NES-
GFP2-M9 (Fig. 9B) or the NES-GFP2-cNLS 
(Fig. 9C) reporters using plasmid-encoded 
ICP27 mutant proteins. Previously in mutant 
virus infections most of the ICP27 proteins 
carrying N-terminal deletions were able to 
interact with Nup62, whereas C-terminal point 
mutants were not (Fig. 7B). When co-expressed 
from exogenously introduced plasmids, these 
ICP27 mutants had variable effects on the 
localization of the reporter proteins. NES-GFP2-
M9 and NES-GFP2-cNLS reporters localized 
also to the cytoplasm in 70 and 80% of cells 
when co-transfected with the ICP27 N-terminal 
deletion mutants 10-512 and 166-512 
respectively (Fig. 9B and C, middle panels). The 
N-terminal mutant 10-512, which deletes only 
part  (aa6-9) of ICP27 NES (aa6-19) in 70% of 
cells showed the phenotype similar to full length 
WT ICP27 protein (first panels). In some cells 
(20% cells) nuclear retention of the reporter 
protein was observed. Whereas for the ICP27 
mutant 166-512, altered cytoplasmic 
redistribution was seen in more cells (80%) 
compared to nuclear retention (10%). This is in 
agreement with most of the ICP27 proteins 
carrying N-terminal deletions able to interact 
with Nup62 except dleu where NES region alone 
is missing. Additionally, it indicates existence of 
alternative routes for shuttling for these N-
terminal mutants’. Loss of interaction in dleu 
may possibly be due to unavailability of 
interacting sites as a result of altered folding of 
the mutant protein. Whereas the C-terminal 
deletion mutant 1-403 and the M15 C-terminal 
ICP27 point mutant that do not bind to Nup62 
did not alter the distribution of the either of the 
reporters significantly. The staining remained 
mostly in the nucleus in dual co-expressing cells 
(Fig. 9B and C, last middle panels). 
Representative images for are shown in Fig. 9B 
and C. These results further strengthen the 
importance of the C-terminal region and ICP27-
Nup62 interaction for ICP27 activity. 
 
 
DISCUSSION 
 
Herpesviruses are nuclear replicating DNA 
viruses that need to transport mRNAs and 
proteins across the nuclear envelope because of 
the compartmentalization of the host cellular 
transcription and translation machinery upon 
which the virus depends. Viruses use a variety of 
mechanisms to selectively block host mRNA 
export. Understanding the molecular basis of 
these mechanisms has important implications for 
developing novel anti-viral treatments. Previous 
studies on ICP27 interactions with the cellular 
transport machinery have mostly examined the 
roles for ICP27-mediated viral RNA export 
utilizing the cellular mRNA export receptor TAP 
that allows the intronless herpesvirus mRNAs to 
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be preferentially transported. To date the 
mechanism for shuttling of viral RNA-
independent free ICP27 has remained 
inconclusive (47) as ICP27 export is NES 
region-mediated but not dependent on the 
receptor CRM1, which is the major NES-
recognizing cellular export receptor. 
Additionally, in virus-infected mammalian cells 
where ICP27 substrate viral RNAs are also 
present, ICP27 mRNA export is shown to be 
TAP dependent using siRNAs to TAP (47-49). 
However, export of free ICP27 not bound to 
viral RNA is TAP-independent because 
constitutive transport element did not inhibit 
ICP27 export when tested by nuclear 
microinjection in Xenopus oocytes (47). Binding 
of ICP27 to specific viral RNA substrates could 
alter either ICP27 conformation or the 
ICP27/RNA/partner protein complex 
configuration. The interaction between ICP27 
and Nup62 demonstrated here is the first 
example of herpesviruses able to directly utilize 
NPC core components and may provide an 
explanation for discrepancies in attempts to 
explain ICP27 shuttling. This interaction appears 
to be functionally relevant as WT ICP27, but not 
C-terminal mutants that failed to interact with 
Nup62, can inhibit transport of substrates of 
some of the cellular transport receptors tested. 
Such an interaction would provide advantage to 
the virus as ICP27 may compete with and block 
transport of host substrates.  
TAP- and CRM1-mediated export 
pathways converge at the NPC as CRM1 
competes strongly with TAP for binding to 
Nup214 and prevents export by the TAP 
transport domain (71). Competition for binding 
to a Nup at the nuclear pore is a possible 
explanation for the inhibition by ICP27 of 
transport of reporter substrates observed here. 
As an example of import pathways converging 
at the NPC, transportin inhibited karyopherin 
α/β1-mediated import of a classical NLS 
containing substrate and, vice versa, karyopherin 
β1 inhibited transportin-mediated import of the 
hnRNP A1-based substrate, suggesting that the 
two import pathways merge at the level of 
docking of β1 and transportin to Nups (8,9). 
Thus ICP27 may shuttle by utilizing different 
components of the host transport machinery, 
possibly varying pathways at different stages of 
the viral replication cycle. 
Several cellular and viral proteins 
continuously shuttle between nuclear and 
cytoplasmic compartments, including 
heterogeneous nuclear RNP (hnRNP) proteins 
(72,73), U1 small nuclear RNP-specific protein 
U1A (74) and influenza virus NS1 (75) and 
HIV-1 Rev protein (76). Although the 
physiological significance of nuclear shuttling is 
not known in all cases, some RNA-binding 
shuttling proteins have roles in mRNA export. 
hnRNP A1 associates with RNA polymerase II-
derived-transcripts in both the nucleus and 
cytoplasm and is thought to directly mediate 
their transport (73). ICP27 is able to efficiently 
shuttle in the presence of CRM1 inhibitor LMB, 
as addition of LMB did not inhibit the export of 
ICP27 (77). These recent data and several earlier 
reports (47-49) show that ICP27 does not require 
CRM1 for its nuclear export. ICP27 interacts 
with Aly/REF, which recruits the TAP cellular 
mRNA export pathway (47,49) and TAP/NXF1 
is required for export (48). However, recent data 
show that Aly/REF is dispensable for ICP27-
mediated export of HSV mRNA (78). Moreover, 
Aly/REF knockdown has little effect on viral 
RNA export (42). HIV-1 Rev protein binds to 
Rev-response elements in viral mRNAs to 
mediate their export and also interacts with core 
Nups via CRM1 (79). HSV-1 ICP27 is known to 
bind intronless RNAs and function in their 
export (reviewed in 28,29) and we postulate that, 
like HIV Rev, ICP27 could use core Nups in this 
transport process.  
Using a heterokaryon assay able to test 
the shuttling activity of proteins, ICP27 WT was 
able to shuttle efficiently (80). Shuttling of some 
of the ICP27 mutants has also been tested. 
Mutant d1-2 (which deletes aa12-63, including 
part of NES: aa 6-19) showed reduced shuttling 
(80). The ICP27 M15 C-terminal point mutant 
completely abrogates shuttling activity (80). 
M15 virus is totally replication defective (57). 
Whereas, deletion of ICP27 NES (aa 6-19) in the 
dleu mutant weakened but did not abrogate 
shuttling and dleu is replication deficient (77).  
That mutations in amino acids 6-11 at 
the N-terminus and mutations at the C-terminus 
of ICP27 both affect the interaction in vitro with 
bacterially purified Nup62 suggests that both 
regions of ICP27 may act together for Nup62 
binding. However, N-terminal mutant 10-512, 
which deletes part  (aa 6-9) of ICP27 NES (aa 6-
19) when used in the transport assay, in 70% of 
cells showed the phenotype similar to full length 
WT protein. In fewer cells nuclear retention of 
the reporter protein was also observed. Our 
observations are similar to the ones reported 
earlier that mutant d1-2 (which deletes aa12-63, 
including part of NES-aa 6-19) showed reduced 
shuttling (80) and in the dleu mutant deletion of 
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NES (aa 6-19) of ICP27 weakened but did not 
abrogate shuttling. Mutant ICP27 dleu virus is 
replication deficient (77) but not replication 
defective. Hence, for these N-terminal mutants’ 
alternative routes for nuclear egress appear to 
exist when other regions of the protein 
especially the C-terminus are intact. Our 
observations are not quantitative in nature but 
help to understand the role(s) played by various 
segments of ICP27. From the ICP27-Nup62 
interaction even in the presence of LMB 
(Supplementary Fig. S2) and from transport 
assays utilizing various N- and C-terminal 
ICP27 plasmid mutations, it becomes clear that 
though the N-terminal region of ICP27 affects 
its ability to bind Nup62 in vitro, functionally it 
appears to be the C-terminus of ICP27 that acts 
as the major region of importance for shuttling 
of viral protein. These data revealed that mutants 
that reduce protein-protein interactions with 
Nup62 at the C-terminus alter and dramatically 
decrease the ability of ICP27 to shuttle and also 
inhibit multiple host cell nucleo-cytoplasmic 
transport pathways. The ICP27 M15 mutant 
protein appears to be able to enter the nucleus 
after synthesis in the cytoplasm via alternative 
routes; however, its ability to export out of 
nucleus seems to be defective. Loss of Nup62 
interaction correlates with the inability of M15 
to re-export and shuttle continuously and it 
appears that as a result of loss of this crucial 
function M15 is replication defective (57). With 
regards to cellular and viral mRNA processing, 
HeLa cells infected with M15 mutant virus 
failed to accumulate cellular unspliced α–globin 
pre-mRNA and mutation in the M15 virus 
greatly increase the length and heterogeneity of 
the poly(A) tail of spliced !α–globin mRNA 
(81). Additionally, ICP0 is one of the few intron-
containing viral genes and it yielded no 
detectable intron 1-containing transcripts in M15 
infections (81). M15 protein has been reported to 
have an exclusively nuclear distribution (80)  
and in contrast to the WT ICP27 protein, the 
M15 mutant protein was absent from the 
polyribosome fractions (40). It remains possible 
however, that the M15 mutation might affect 
other activities of ICP27 than NPC interaction. 
Involvement of the CRM1-independent, 
extreme N-terminus leucine-rich NES region of 
ICP27 in its interaction with Nup62 may simply 
be due to a structural requirement of ICP27 in 
forming a viable conformation in vivo. Recent 
data indicates that ICP27 can acquire an 
intramolecular head-to-tail conformation (45) 
that could provide such a binding site involving 
both ends of the ICP27 molecule. The 
intramolecular head-to-tail configuration 
prevents the interaction of ICP27 with RNA pol 
II (45). It is tempting to speculate that certain 
post-translational modifications of ICP27 during 
infection, such as its phosphorylation and 
arginine methylation (58,82), could direct such 
changes in conformation. This conformational 
alteration may promote specificity and/or 
preference for certain partner proteins such as 
Nup62 or TAP, especially as both of these 
modifications are important for ICP27 export, 
viral replication and gene expression functions 
(83,84). ICP27 also multimerizes via its C-
terminus, which could generate large complexes 
resulting in increased binding sites available for 
Nup62 and/or transport receptors. The study of 
the relationship between ICP27 structural 
conformations and regulation of binding partners 
will be an important area for future work. 
RNA viruses that replicate exclusively 
in the cytoplasm block host transport completely 
e.g. by active degradation of Nup62 and Nup153 
in poliovirus and rhinovirus-infected cells. In 
contrast, ICP27 appears to dominantly utilize the 
host transport machinery in support of export of 
intronless viral mRNAs and import of viral 
regulatory and capsid and tegument proteins for 
assembly in the nucleoplasm. Consistent with 
this and an earlier study of NPC component 
localization during herpes virus infection (66) 
we found Nup62 protein intact and properly 
localized in HSV-1 infected cells and an ICP27 
mutant deficient for Nup62 binding failed to 
inhibit cellular nucleocytoplasmic transport 
pathways. It will be interesting in future to test 
for ICP27 interactions with other Nups.  
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SUPPLEMENTAL MATERIALS 
 
Three Supplemental Figures (Figs. S1, S2 and S3). 
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FIGURE LEGENDS 
 
FIGURE 1. ICP27 associates at the nuclear periphery. HeLa cells infected with HSV-1 
vBSGFP27 (encoding wild-type [WT] ICP27 fused to GFP) were extracted with 1% Triton X-100 prior to 
fixation at the post-infection times indicated. This treatment removes protein that is not bound to resistant 
structures such as the nuclear envelope lamina, NPCs, and chromatin. A, After fixation the extracted cells 
were stained for mab414 that recognizes several nucleoporins based on their unique O-linked glycosylation. 
The extraction removed enough of the diffuse nucleoplasmic pool of ICP27-GFP to be able to observe an 
ICP27 rim at the nuclear envelope that co-localizes with the NPC. Arrows point to the outer limit of the 
ICP27-GFP and the NPC staining. No co-localization was observed at the 4 h post-infection time point. In 
contrast at 8 and 16 h post-transfection significant co-localization can be observed. One region of the 16 h 
post-infection time point is enlarged in the lower panels.  B, The same experiment as in A was performed 
except that the transport receptor TAP, which has previously been shown to interact with ICP27, was stained 
for instead of the nucleoporins. Here small, boxed sections are enlarged in some panels to more clearly 
observe the co-localization between ICP27 and TAP and two panels for each time point are shown. All 
images are deconvolved from stacks with individual sections shown and scale bars for both A and B are 10 
µm.  
 
FIGURE 2. Nup62 integrity during HSV-1 infection. A, Nup62 protein is stable in HSV-1 infected 
cells. Lysates were prepared from mock infected HeLa cells or HeLa cells infected with WT HSV-1 17+ or 
an HSV-1 mutant with a deletion of the ICP27 gene (∆27). Cell lysates shown were prepared at 2, 4, and 24 
h post-infection. MOIs used here are 10 for 2 and 4 h time points and 1 for 24 h. Each lysate was reacted on 
Western blots with Abs to ICP27, Nup62, and GAPDH as a loading control. No obvious differences were 
observed in Nup62 protein levels at any of the time points. B, Nup62 localization is also similar in HSV-1 
infected cells. HeLa cells either mock or WT HSV-1 vBSGFP27-infected were fixed directly at 3 hpi and 18 
hpi and then permeabilized and stained with Nup62 Abs. Viral ICP27 expression from its endogenous 
promoter tagged with GFP confirmed that individual cells were infected with HSV-1. The distribution of 
Nup62 remained mostly peripheral in mock and virus infected cells at early time points (3 hpi). At 18 hpi 
some distinct cytoplasmic speckles of Nup62 were also seen although nuclear rim localization of Nup62 was 
still maintained. The vBSGFP27 virus used here has a slightly slower growth rate compared to WT HSV-1 
(52). Arrows point to regions with particular clustering of Nup62. 
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FIGURE 3. Co-immunoprecipitation of ICP27 and Nup62. A, ICP27 Abs co-immunoprecipitate 
Nup62. Left panels, Abs against ICP27 were incubated with extracts from mock infected, WT HSV-1 
infected, and ∆27 infected HeLa cell lysates. Immunoprecipitated complexes were analyzed by Western 
blotting with Abs against Nup62. Nup62 co-immunoprecipitated with ICP27 from WT HSV-1 infected HeLa 
cell extracts, but not from mock or ∆27-infected cell extracts. Reaction of blots with Abs against ICP27 
confirms that ICP27 was only expressed in WT HSV-1 infected cells. Western blots of the unbound material 
in reactions confirmed that Nup62 was present in all reactions. A non-specific mouse serum Ab was used as 
a negative control (ctr) that failed to co-immunoprecipitate either ICP27 or Nup62 in WT HSV-1 infected 
lysates. The band marked with an asterisk is the heavy chain of IgGs used for immunoprecipitations. B, The 
reverse immunoprecipitation reaction also indicates an ICP27-Nup62 interaction. Nup62 Ab (H-122) co-
immunoprecipitated ICP27 from extracts of HeLa cells infected with either WT or a mutant HSV-1 strain 
(M16) carrying a C-terminal point mutant (C488L) in ICP27. As expected no band corresponding to the 
molecular weight of ICP27 was observed co-precipitating with Nup62 Abs from mock ∆27 virus infected 
cell lysates. Again a non-specific control serum Ab (ctr) failed to co-immunoprecipitate either Nup62 or 
ICP27 and Nup62 was immunoprecipitated from all lysates with the Nup62 Abs. The band marked with an 
asterisk is the heavy chain of IgGs used for immunoprecipitations. C, The interaction between HSV-1 ICP27 
and the host organism Nup62 is conserved across species as Nup62 Ab C-16 co-immunoprecipitated ICP27 
from HSV-1-infected BHK cell extracts also. 100 µg of lysate was used for the WT in lane 2 while only 50 
µg was used for the WT in lane 4. Again the control Ab failed to co-precipitate ICP27 from WT infected cell 
extracts. As a positive control for the experiment ICP27 was immunoprecipitated using Abs against ICP27 
from WT HSV-infected cells and run on the same gel and blotted with anti-ICP27 Ab.  
 
FIGURE 4. Interaction of GST-Nup62 and ICP27 does not depend on RNA or virus infection. 
A, Nup62 fused to glutathione S-transferase (GST) and purified from bacteria in absence of any other 
mammalian proteins. Nup62-GST was incubated with WT HSV-1, ∆27, and mock-infected cell extracts or 
with extracts from uninfected cells expressing ICP27 from a plasmid behind the CMV promoter. Upper 
panel, Western blotting with Abs against ICP27. Lower panel, Western blotting with GAPDH Abs as a 
loading control for lysates. Input and pulldowns with GST alone were added on the ends for controls. B, 
GST-Nup62 was incubated with WT HSV-1 infected lysates either with or without RNase I treatment. Again 
GST alone and input are used as controls. C, Rae1, another transport receptor does not pull down ICP27. 
Bacterially purified GST-Rae1 (67 kDa) was incubated with lysates from WT HSV-1, ∆27 null virus, a 
mutant HSV-1 strain (M15) carrying a C-terminal point mutant (P465L:G466E) in ICP27, or mock infected 
cells. Upper panel, Proteins co-purifying on Glutathione Sepharose beads were analyzed by Western blotting 
with Ab against ICP27. GST-Rae1 did not pull down ICP27 from any of the added cell extracts. A doublet 
band running lower in lanes 2-5 and marked with an asterisk is a band from GST-Rae1 bacterial protein 
preparation cross-reacting non-specifically with anti-ICP27 Ab. D, Bacterially expressed GST-Rae1 protein 
from the fusion protein preparation used in binding assays shown in figure 4C was analyzed on a coomassie 
stained gel. Expected full-length protein position is shown with an asterisk while the double asterisks 
indicates cleavage products of the full-length protein. E, GST-Rae1 and GST-TAP pull down known partner 
protein Nup98. Bacterially purified fusion protein GST-Rae1 (67kDa) was incubated in presence of RNase I 
with HSV-1 ∆27 null virus-infected or mock infected cell lysates. Another fusion protein GST-TAP earlier 
shown to interact with Nup98 and GST alone were also incubated with HSV-1 WT virus-infected cell 
lysates. Proteins co-purifying on Glutathione Sepharose beads shown as bound samples and unbound 
leftover samples were analyzed by Western blotting with Ab against Nup98. Mock infected and ∆27 null 
virus-infected cell lysates were loaded as input. Bound samples show that GST-Rae1 pulled down Nup98 
from ∆27 null virus-infected or mock-infected cell lysates and GST-TAP also pulled down Nup98 from WT 
virus-infected lysates. GST alone showed a weak band as background in bound samples, however the 
majority of Nup98 is not pulled down and is present in unbound samples with GST alone whereas not much 
is left as unbound with mock.  
 
 FIGURE 5. The Nup62-ICP27 interaction is direct and TAP also binds ICP27 under similar 
conditions. A, GST-TAP pulls down ICP27 from WT HSV-1 infected cell extracts, but not from extracts of 
cells infected with a viral ICP27 C-terminal point mutant (M15; upper panel) whereas in the same binding 
reactions GST-TAP pulls down Nup62 from WT HSV-1 infected cell extracts, from extracts of cells infected 
with a viral ICP27 C-terminal point mutant (M15), with ICP27-null mutant ∆27 virus, and from mock-
infected cell extracts (upper panel). Bacterially expressed GST or GST-TAP was incubated with extracts 
from WT, ∆27, or M15 infected HSV-1 strains. Proteins co-purifying on Glutathione Sepharose beads were 
analyzed by Western blot with ICP27 or Nup62 Abs. B, ICP27 and TAP co-immunoprecipitate from HeLa 
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cell extracts in the presence of RNase I. Co-immunoprecipitation was carried out by mixing anti-ICP27 
antibodies 1113 and 1119 with HSV-1 WT and ICP27 mutant M15 and null Δ27 viruses and mock infected 
HeLa cell extracts. Complexes formed were separated by SDS-PAGE followed by western blotting with 
anti-TAP and ICP27 Abs. ICP27 co-precipitated TAP; Upper panel shows co-immunoprecipitation of TAP 
in WT infected HeLa cell extracts in the presence of RNase I by ICP27 but no co-immunoprecipitation with 
M15, Δ27 and mock infected. Input, mock infected HeLa cell extract. The lower band in the input lane could 
be due to another cellular protein cross-reacting with this TAP Ab, but the correct size upper band specific to 
TAP is clearly seen. The band marked with an asterisk is the heavy chain of IgGs used for 
immunoprecipitations. ICP27 immunoprecipitated itself: Lower panel shows immunoprecipitation of ICP27 
in WT and M15 infected HeLa cell extracts in the presence of RNase I by its Ab but no immunoprecipitation 
in Δ27 and mock infected cell extracts. C, The purity of various fusion proteins used for in vitro binding 
assays. Coomassie stained 10% SDS-PAGE of bacterially expressed proteins used in figures 4-7. Single 
asterisk indicates the molecular weight of the expected protein product while the double asterisks indicates 
cleavage products of the full-length protein. Pre-stained molecular weight protein markers are loaded on the 
leftmost lane with GST alone. D, Bacterially purified His-tagged ICP27 was incubated with bacterially 
purified GST-Nup62, GST, or GST-TAP proteins on Glutathione Sepharose beads. Protein complexes 
formed were eluted by reduced glutathione and separated by SDS-PAGE and Western blotted with anti-His 
Ab. His-ICP27 interacted with GST-Nup62 and GST-TAP, but not GST alone. E, An unrelated non-specific 
His-tagged fusion protein (His-mRFP) does not interact with GST-tagged TAP or Nup62 fusion proteins. 
Bacterially purified His-tagged mRFP fusion protein was incubated with bacterially purified GST-TAP, 
GST-Nup62 or GST alone on Glutathione Sepharose beads in the presence of RNase I. Protein complexes 
eluted by reduced glutathione and separated by SDS-PAGE are shown on a coomassie stained gel. His-
mRFP (corresponding to the band in input) does not interact with GST-TAP, GST-Nup62 and GST alone in 
bound samples run on gel (upper panel) but His-mRFP is present in all unbound pull down samples run on 
coomassie (lower panel). Purified His-mRFP alone protein added to the pull down reactions was loaded as 
input. Molecular weight protein marker sizes are given in kDa on the left.  
 
 FIGURE 6. Nup62 interacts with ORF57, an ICP27 homologue from KSHV. A, Mock-infected 
HeLa extracts were incubated with either GST-ICP27, GST-ORF57 — a homologue of ICP27 from Kaposi’s 
sarcoma-associated herpesvirus (KSHV), or GST alone. Complexes isolated on Glutathione Sepharose beads 
were eluted after washing, separated on 10% SDS-PAGE, transferred to nitrocellulose membranes and 
incubated with Abs against Nup62. Both ICP27 homologs pulled down Nup62. 33% of the HeLa cell 
extracts used for binding was loaded as input and 1/2 of the pull down reaction samples eluted from the 
beads was loaded on the gel. Lower band marked with asterisk in lane 2 is a band from GST-ICP27 protein 
preparation cross-reacting non-specifically with Nup62 Ab. B, Control protein GAPDH did not bind to 
ICP27 and ORF57 fusion proteins. Pulled down reactions of ICP27, ORF57 fusion proteins and GST alone 
with HeLa lysates were blotted with anti-GAPDH Ab and this showed GAPDH present only in the input and 
not pulled down in bound samples. C, Coomassie stained 10% SDS-PAGE of bacterially expressed proteins 
GST-ICP27, GST-ORF57 and GST alone present on the beads used in the binding reactions here and in 
figure 5A. Single asterisk indicates the molecular weight of the expected protein product while the double 
asterisks indicate cleavage products of the full-length protein.  
 
 FIGURE 7. Mapping of Nup62 interaction sites on ICP27. A, Schematic of ICP27, N-terminal 
deletion mutants, and C-terminal point mutants. The NES, NLS, and the RGG viral RNA binding site are 
marked along with the three hnRNP K homology domains (KH1-3). In the third conserved domain are the 
Sm and Zn finger regions that are respectively disrupted by the M15 (P465L:G466E) and M16 point 
mutations (C488L) (57) and are respectively represented with double and single asterisks. B, GST-Nup62 
was incubated with lysates from cells infected with herpesviruses carrying the listed ICP27 mutations. The 
material that bound to GST-Nup62 and eluted from Glutathione Sepharose beads is shown in the upper 
panels while the unbound is shown in the lower panels to confirm that the viral proteins were expressed. All 
co-precipitated proteins are visualized with the ICP27 monoclonal Abs; either 1113 or 1119 as 1113 Ab is 
raised against a region of ICP27 that is missing in mutant d3-4 and 1119 Ab is raised against a region that is 
missing in dleu mutant. Standard GST alone and input controls were employed. 
 
FIGURE 8. ICP27 blocks both NLS and M9-mediated nucleocytoplasmic transport pathways. 
A, Left panels, ICP27 accumulates both in the nucleoplasm and the cytoplasm of uninfected cells transfected 
with a WT ICP27-encoding plasmid. Middle panels, HeLa cells were transfected with a plasmid encoding 
just a NES-GFP2-M9 reporter that contains the CRM1-dependent NES of HIV-1 Rev and the transportin-
dependent M9-NLS of hnRNPA1. This construct accumulates in the nucleoplasm when transfected alone, 
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but in the cytoplasm when co-transfected with ICP27 (right panels). B, NES-GFP2-M9 reporter construct 
when co-transfected with ICP27 encoded from pTriEx-ICP27 WT plasmid also accumulates predominantly 
in the cytoplasm. C, Similarly, a different reporter was used (NES-GFP2-cNLS) that contains the CRM1-
dependent REV NES and the importin/karyopherin α/β-dependent (classical) NLS. It accumulates in the 
nucleoplasm when expressed alone (left panels) and in the cytoplasm when both ICP27 and NES-GFP2-
cNLS are co-transfected (right panels). Scale Bar, 10 µM. 
 
FIGURE 9. Effect of ICP27 mutants on both NLS and M9-mediated nucleocytoplasmic 
transport pathways. A, Schematic of mRFP-M15 ICP27 point mutant fusion protein, N-terminal, and C-
terminal deletion mutants. Sm region is disrupted by the M15 (P465L:G466E) point mutations (57) with the 
position of the mutation shown with double asterisks. N-terminal (aa10-512, 166-512) and C-terminal (aa1-
403) deletion mutants are expressed from pTriEx-1.1 vector. B, The NES-GFP2-M9 reporter construct 
accumulates in both the cytoplasm and nucleoplasm when co-transfected with a plasmid encoding WT 
ICP27 fused to mRFP (mRFP-ICP27 WT) or several N-terminal deletion mutants (pTriEx-ICP27 aa10-512, 
166-512), but with the M15 ICP27 C-terminal point mutant and the C-terminal deletion mutant (pTriEx-
ICP27 aa1-403), the reporter accumulated in the nucleoplasm indicating that an intact functional C-terminus 
is required. C, The NES-GFP2-cNLS reporter construct accumulated in the cytoplasm when co-transfected 
with ICP27 encoded from mRFP-ICP27 WT and N-terminal deletion mutants, but when cells were instead 
co-transfected with the M15 ICP27 point mutant or the C-terminal (aa1-403) deletion mutant the reporter 
accumulated in the nucleoplasm.  
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